{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2007"],"data_sharing_plan":["IPD Sharing (as of May 2017): Yes\nDescription: http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf\nhttp://engagezone.msd.com/ds_documentation.php"],"condition":["","Advanced Aerodigestive Tract Cancers (Colorectal Cancer (CRC), Non Small Cell Lung Cancer (NSCLC), Head and Neck (H&N), Esophageal Cancer","Colorectal Neoplasm","Carcinoma, Non-Small-Cell Lung","Esophageal Neoplasm","Head and Neck Neoplasm","9 Colon, unspecified-C349 Bronchus or lung, unspecified-C760 Head, face and neck-C159 Oesophagus, unspecified","Neoplasms","Head and Neck Neoplasms","Head, face and neck","Neoplasm","Oesophagus, unspecified","Esophageal Neoplasms","Colorectal Neoplasms","Bronchus or lung, unspecified","Colon, unspecified"],"disease":["","Colon, Unspecified","Advanced Aerodigestive Tract Cancers (colorectal Cancer (crc), Non Small Cell Lung Cancer (nsclc), Head And Neck (h&n), Esophageal Cancer","Colorectal Neoplasm","Head And Neck Neoplasm","Esophageal Neoplasm","Head And Neck Neoplasms","Neoplasms","Neoplasm","Bronchus Or Lung, Unspecified","Head, Face And Neck","Esophageal Neoplasms","Colorectal Neoplasms","Carcinoma, Non-small-cell Lung","9 Colon, Unspecified-c349 Bronchus Or Lung, Unspecified-c760 Head, Face And Neck-c159 Oesophagus, Unspecified","Oesophagus, Unspecified"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2036207"],"location":["Puerto Rico","Czechia","United States","United Kingdom","Portugal","Switzerland","Spain","Greece","Canada","Netherlands","Sweden","Brazil","Mexico","Italy","Australia"],"study_start_month":["1"],"keyword":["Temozolomide"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)","description":"This study is proposed to evaluate the efficacy and safety of temozolomide, an oral anti-cancer agent, in a participant population selected for a biomarker. Participants with colorectal cancer, non-small-cell lung cancer, head and neck cancer, or esophageal cancer will be included.","dates":{"creation":"2007-01-15"},"accession":"2036207","cross_references":{"ClinicalTrials___gov":["NCT00423150"],"EU Clinical Trials Register":["2006-003169-15"],"Registro Peruano de Ensayos Clínicos":["PER-023-07"]}}